Hetero Drugs

From WikiMD's WELLNESSPEDIA

Hetero Drugs is a pharmaceutical company based in India. It was established in the year 1993 and has since grown to become one of the largest manufacturers and marketers of pharmaceutical products in Hyderabad, India. The company specializes in the areas of pharmacology, biotechnology, and active pharmaceutical ingredients (APIs).

History[edit]

Hetero Drugs was founded by Dr. B. Parthasaradhi Reddy, a renowned scientist and entrepreneur in the field of pharmaceuticals. The company started with a small manufacturing unit and has since expanded its operations to over 120 countries worldwide.

Products and Services[edit]

Hetero Drugs offers a wide range of pharmaceutical products and services. These include:

  • Active Pharmaceutical Ingredients (APIs): Hetero Drugs is one of the world's largest producers of APIs. The company manufactures over 200 APIs which are used in the production of various drugs.
  • Generic drugs: Hetero Drugs is a leading manufacturer of generic drugs. The company offers a wide range of generic drugs in various therapeutic categories.
  • Biologics: Hetero Drugs is also involved in the development and manufacturing of biologics. The company's biologics division focuses on the development of biosimilars and novel biologics.
  • Contract manufacturing: Hetero Drugs offers contract manufacturing services to other pharmaceutical companies. The company's contract manufacturing division is equipped with state-of-the-art facilities and follows strict quality control measures.

Research and Development[edit]

Hetero Drugs has a strong focus on research and development. The company's R&D division is involved in the development of new drugs, improvement of existing drugs, and the development of new drug delivery systems. The R&D division also works on the development of biosimilars and novel biologics.

Regulatory Approvals[edit]

Hetero Drugs has received regulatory approvals from various international regulatory bodies. These include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO).

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.